Hi Group,
I just wanted to post to say that this is my 4th year anniversary of
my diagnosis with CML. You guys have really been there for me during
some very dark days, and I am very grateful for your support.
Thanks so much!
Kristin
dx 3-5-01, chronic phase
ccr 12-15-01
pcru at COH and UCLA
Hi Group,
I did the focus forward interview today. It was conducted by a lovely
woman who is also a cancer survivor. For you with any trepidations
about an interview conducted in your home, I can tell you that mine
was like having a friend come over for coffee.
I can tell you that it is for
Patients with Serious Illness Appear to Adapt Well
Fri Feb 11, 4:37 PM ET
Add to My Yahoo! Health - Reuters
By Alison McCook
NEW YORK (Reuters Health) - Most people who live with serious
disability or illness, such as kidney failure, appear to adapt well
and maintain a
Hey Group,
Just a reminder that today is Day 0 for Dane...His BMT occurs today.
If you haven't already, consider dropping him an encouraging note at
his Caring Bridge site...Leave some beautiful words for the guy who
leaves us all of the beautiful images.
http://www3.caringbridge.org/tx/dane/
Hi Deanna,
Here's a link to their site
http://www.focusfwdonline.com
I agreed to participate. My interview is scheduled for February 20th.
Warm Regards,
Kristin
--- In CML@yahoogroups.com, Deana Brenner [EMAIL PROTECTED] wrote:
Hi Rob
I answered the enclosed e-mail and received an
--- In CML@yahoogroups.com, jennifer g [EMAIL PROTECTED] wrote:
You're right that IE is the most vulnerable. A new browser called
Firefox is now available that is supposed to be less vulnerable. Some
people like it better than IE (or Netscape - unfortunately, most Web
sites aren't optimized
--- In CML@yahoogroups.com, Barbara Meunier [EMAIL PROTECTED] wrote:
I'm sorry to go on but this trisomy 8 thing's driving me mad. I
can't sleep nor eat and all I do is think about it. I know that
some have you have seen it come and go but I've got it in 60% of my
cells and I keep
17 Substances Added to Cancer Agents List
WASHINGTON - The government is adding viruses for the first time to
its list of known or suspected causes of cancer, including hepatitis B
and C and a third virus that causes sexually transmitted diseases.
Lead, X-rays and compounds in grilled meats
Bone Marrow Matches Hard for Multiracial
By ERIN TEXEIRA, AP National Writer
Luke Do was a lively 18-month-old awaiting the birth of his first
sibling when he was diagnosed with a rare form of leukemia. The hopes
of his parents, both doctors in San Jose, Calif., immediately turned
to a bone
Amgen Warns About Higher Doses of Anemia Drugs
By Susan Heavey
WASHINGTON (Reuters) - Amgen Inc. has added a warning to its anemia
drug, Aranesp, for kidney dialysis and cancer patients after studies
on similar drugs showed higher doses can cause blood clots and death,
the company said a
Painkillers Damage Intestine, U.S. Expert Says
By Maggie Fox, Health and Science Correspondent
WASHINGTON (Reuters) - More than 70 percent of patients who took
painkillers such as ibuprofen for more than three months suffered
damage to their small intestines, U.S. researchers reported on
Rule May Let Workers Keep Health Coverage
By JOHN HEILPRIN, Associated Press Writer
WASHINGTON - For U.S. workers who change or lose their jobs, a new
rule issued by the Bush administration just before the end of 2004
could provide better access to group health plan coverage in keeping
with
--- In CML@yahoogroups.com, Karen Andrews [EMAIL PROTECTED]
wrote:
With all of the lousy news lately (sandra, dane...), I wanted to
share a bit of hopeful encouragement. I had a cbc today (8 days
after starting the rad trial) and my wbc went from 20.1 to 13.7.
And my differential was
New Leukemia Drugs Work Better, Studies Show
By Maggie Fox, Health and Science Correspondent
WASHINGTON (Reuters) - Next-generation leukemia pills, designed to
help patients not cured by the successful drug Gleevec, work even
better than doctors had hoped, researchers said on Sunday.
One
New Leukemia Drugs May Prove
More Potent Than Gleevec
By RON WINSLOW and JEANNE WHALEN
Staff Reporters of THE WALL STREET JOURNAL
December 6, 2004
In a provocative new advance in the war on cancer, researchers say
two experimental drugs produced striking early results for patients
whose
Leukemia Drug Gleevec Continues to Amaze
By E.J. Mundell
HealthDay Reporter
FRIDAY, Dec. 3 (HealthDayNews) -- It was late 1997 and Doug Jensen,
71, of Canby, Ore., thought he'd developed a particularly stubborn
cold. But his symptoms dragged on and kept getting worse, he said.
Then Jensen
--- In [EMAIL PROTECTED], Dane T. [EMAIL PROTECTED] wrote:
Nancy Wilhem gave me a wonderful gift of an oil painting done from
one of my photographs. Check out how talented she is!
Thanks again Nancy.
A wonderful gift.
http://www.fototime.com/71AF691458B0FDC/orig.jpg
At 09:37 PM 11/6/2004, nancy wilhelm intelligently penned
Well, kids, here we go again!!
Bob is in the hospital with pneumonia. Went to ER on Thursday
evening and
they admitted him about 1 am Friday. He is very much better now
and will
probably be released on Monday. I've spent
--- In [EMAIL PROTECTED], Karen Andrews [EMAIL PROTECTED]
My dr originally saw diahhria as just an annoyance that aggravated
me. However, I am convinced that it is much more serious than that.
I really think it has some impact on how well gleevec is abosorbed
into your body. Before the
Scientists Tout Method of Attacking Tumors
By DIEDTRA HENDERSON, AP Science Writer
WASHINGTON - Texas researchers say they have perfected a method to
deliver cancer treatment directly into tumors, bypassing healthy
tissue.
The study was done on mice, but human trials could begin soon,
Study Finds Fewer Cancer Research Deaths
By LINDSEY TANNER, AP Medical Writer
CHICAGO - Patient deaths from experimental cancer drugs during
initial human studies declined dramatically from 1991 to 2002,
suggesting that better oversight and less-toxic medicines have made
cancer research
--- In [EMAIL PROTECTED], Dane T. [EMAIL PROTECTED] wrote:
Hello all. I am back home after two weeks as an outpatient at
MDACC.
I am in a combo trial for Zarnestra and Gleevec.
The first 2 weeks called for 400mg Zarnestra in the morning and
400mg Gleevec at night. The first 4 days
Dear Sandra,
Thank you for keeping us updated on issues of concern. I also
appreciate your posts.
With Appreciation,
Kristin
Yahoo! Groups Sponsor ~--
$9.95 domain names from Yahoo!. Register anything.
--- In [EMAIL PROTECTED], lindabones9 [EMAIL PROTECTED] wrote:
Kristin and All,
I just returned from a monthly LL CML support group meeting. So
nice
to see some of our friends from here!
Kristin, I see that you know all the housekeeping genes from
everywhere and thought you could answer
Drug Makers Explain Trials to Congress
By DIEDTRA HENDERSON, AP Science Writer
WASHINGTON - Drug manufacturers acknowledge they face a crisis of
credibility that they hope to remedy by releasing information about
their clinical trials in multiple locations.
But at a contentious
Few Apply for Medicare Drug Coverage
By MARK SHERMAN, Associated Press Writer
WASHINGTON - Far from the expected deluge, relatively few patients
with cancer and other serious illnesses have applied for generous
early Medicare prescription drug coverage.
The Bush administration was
26 matches
Mail list logo